
中东低分子量肝素市场预测至 2028 年 – COVID-19 影响和区域分析 – 按产品(依诺肝素、达肝素、亭扎肝素、速肝素、那屈肝素等)、包装(多瓶和预充式注射器) )、应用(深静脉血栓、急性冠状动脉综合征、肺栓塞等)、最终用户(医院、诊所、门诊手术中心等)和分销渠道(医院药房、零售药房等)
No. of Pages: 216 | Report Code: BMIRE00027299 | Category: Life Sciences
No. of Pages: 216 | Report Code: BMIRE00027299 | Category: Life Sciences
中东低分子肝素市场预计将从2021年的1.5115亿美元增长到2028年的209.60美元。预计2022年至2028年复合年增长率为4.8% .报告重点介绍了推动市场增长的主要趋势和因素。
中东低分子肝素市场的增长归因于低分子肝素的优势低分子肝素抗凝剂优于普通肝素 然而,低分子肝素的不利影响阻碍了整体市场的增长。
低分子肝素(LMWH)是一类抗凝剂。它们用于预防血栓和治疗静脉血栓栓塞(深静脉血栓和肺栓塞)以及治疗心肌梗塞。 LMWH 被定义为平均分子量小于 8,000 道尔顿的肝素盐,其中至少 60% 的链分子量小于 8,000 道尔顿。这些是通过聚合肝素的各种分级或解聚方法获得的。低分子量肝素比肝素具有更好的生物利用度和更长的半衰期、简化的剂量、可预测的抗凝反应以及更低的骨质疏松风险。
低分子量肝素抗凝剂相对于普通肝素的优势
普通肝素(UFH)的作用或标准肝素因患者而异。因此,只能在监护下对住院患者进行治疗。然而,低分子量肝素 (LMWH) 可以每天皮下注射,无需监督。此外,LMWH 与普通肝素相比具有可预测的药代动力学特性,因此可以根据实验室监测以固定剂量给药,无需调整剂量。低分子量肝素的分子量约为 3,500 – 8,000 道尔顿,而普通肝素的分子量为 15,000 道尔顿;
此外,LMWH 不太可能诱发免疫性过敏性血小板减少症,这是普通肝素 (UFH) 引起的严重副作用。 )。对于患有动脉血栓形成的患者来说,这种副作用通常很复杂。此外,与普通肝素相比,LMWH 具有更好的生物利用度、可预测的剂量反应和更长的血浆半衰期等特性,使其成为抗凝治疗的首选。
LMWH 抗凝剂可预防血液凝固和血管中现有血块的生长。近年来,血栓形成的预防方法以及药物和手术治疗的发展有了很大的进步。过去二十年来,LMWH 一直用于治疗抗血栓疾病。 LMWH 具有抗肿瘤、抗炎和抗增殖等抗凝血特性,可用于治疗肾病综合征和阿尔茨海默氏病等疾病。因此,LMWH 抗凝剂相对于普通肝素的优势正在推动中东低分子肝素市场的发展。
COVID-19大流行对中东低分子肝素市场的影响
在过去的几十年里,中东国家加强了卫生系统,升级公共和商业医疗保健。然而,资源有限(包括训练有素的工作人员和医疗设备)和非传染性疾病的负担损害了该地区的整体医疗保健系统。2020 年,COVID-19 大流行对医疗服务的提供和可及性产生了重大影响。社会服务、教育、健康和营养、医疗保健支出和福祉。由于该地区对贸易和旅游业的依赖,以及青年人大量失业的问题,全球危机对该地区造成了严重的长期影响。中东各国政府分配资金,以防止其卫生系统负担过重,并在 2020 年减缓 COVID-19 的传播;一些国家还强调增加重症监护病房和病床数量。
根据美国国立卫生研究院(NIH)报告(2020),低分子肝素COVID-19 大流行期间利用率很高。在 COVID-19 引起的急性呼吸窘迫综合征中,肺部无法充满足够的空气,导致住院患者低氧血症和高死亡率。因此,临床表现明显最差的患者通过软雾吸入器服用低分子肝素,每次 4000 IU,每天两次。
公司采用了各种有机和无机策略。经营中东低分子肝素市场。有机战略主要包括产品发布和产品批准。此外,市场上出现的无机增长策略包括收购、合作和伙伴关系。这些增长战略使市场参与者能够扩大业务并增强其地域影响力,从而促进整体市场的增长。此外,收购和合作战略有助于市场参与者加强其客户群并扩大其产品组合。下面列出了中东低分子肝素市场主要参与者的一些重大进展。
美国医学会、英国外科杂志和国家医学图书馆是准备药物时参考的主要一手和二手资料来源。中东低分子肝素市场报告。
Strategic insights for Middle East Low Molecular Weight Heparin involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
Report Attribute | Details |
---|---|
Market size in 2021 | US$ 151.15 Million |
Market Size by 2028 | US$ 209.60 Million |
Global CAGR (2022 - 2028) | 4.8% |
Historical Data | 2019-2020 |
Forecast period | 2022-2028 |
Segments Covered |
By 产品
|
Regions and Countries Covered | 中东和非洲
|
Market leaders and key company profiles |
The regional scope of Middle East Low Molecular Weight Heparin refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The Middle East Low Molecular Weight Heparin Market is valued at US$ 151.15 Million in 2021, it is projected to reach US$ 209.60 Million by 2028.
As per our report Middle East Low Molecular Weight Heparin Market, the market size is valued at US$ 151.15 Million in 2021, projecting it to reach US$ 209.60 Million by 2028. This translates to a CAGR of approximately 4.8% during the forecast period.
The Middle East Low Molecular Weight Heparin Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Middle East Low Molecular Weight Heparin Market report:
The Middle East Low Molecular Weight Heparin Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Middle East Low Molecular Weight Heparin Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Middle East Low Molecular Weight Heparin Market value chain can benefit from the information contained in a comprehensive market report.